Breaking News Instant updates and real-time market news.

GBT

Global Blood Therapeutics

$22.50

0.2 (0.90%)

13:55
10/05/16
10/05
13:55
10/05/16
13:55

Global Blood weakness attributed to doctor questioning at panel, Bloomberg says

Shares of Global Blood Therapeutics (GBT) have slid to their worst levels of the session, which Bloomberg attributes to doctors questioning GBT400 during a panel at the Cowen conference. Global Blood shares are down 9% to $20.48 in afternoon trading.

GBT Global Blood Therapeutics
$22.50

0.2 (0.90%)

06/10/16
JANY
06/10/16
NO CHANGE
Target $71
JANY
Buy
Janney lowers bluebird bio target to $71 after 'compelling' peer data
Following new 90-day results from Global Blood Therapeutics (GBT) for its GBT440 drug in sickle cell disease patients, Janney Capital analyst Debjit Chattopadhyay said "the onus is now on" bluebird bio (BLUE) to rapidly advance process improvements in the clinic, adding that the "implications of the ASH16 data for the Lentiglobin platform cannot be understated." Based on revised market share assumptions, Chattopadhyay lowered his fair value estimate on bluebird to $71 from $91 but maintains a Buy rating on the stock.
06/13/16
LEER
06/13/16
NO CHANGE
Target $67
LEER
Outperform
bluebird can co-exist with rivals in hemoglobinopathies market, says Leerink
Leerink analyst Michael Schmidt says bluebird bio (BLUE) shares were weak on Friday following the presentation of competitor data from Global Blood Therapeutics (GBT) and Acceleron (XLRN) in sickle-cell disease and beta-thalassemia, respectively, at the European Hematology Association's congress. However, the analyst believes that given the differences between the treatment approaches and the likely different effect size and target patient population, both products could co-exist with bluebird's LentiGlobin within the hemoglobinopathies market. Schmidt reiterates an Outperform rating and $67 price target on bluebird's shares.
06/17/16
EAMC
06/17/16
NO CHANGE
Target $58
EAMC
Buy
Global Blood Therapeutics GBT440 data is promising, says Empire
Empire analyst Dr. Cathy Reese said GBT440's EHA 2016 Phase I/II data presented on June 10 at the the European Hematology Association's 2016 annual meeting in Copenhagen, Denmark looks promising. Reese said the single center data in 27 patients provides reassurance that GBT440 has potential to be a successful therapy for SCD patients. While the GBT440 data was from an early-stage trial and in a limited number of patients, GBT440 seemed to demonstrate a relatively steady improvement in the patients' hemolysis markers and exhibited acceptable tolerability. The next step in GBT440's development should be a meeting with the FDA this summer to begin to formulate the next clinical development steps for the drug. Dr. Reese rates Global Blood a Buy with a $58 price target on shares.
09/30/16
WELS
09/30/16
INITIATION
WELS
Outperform
Global Blood Therapeutics initiated with an Outperform at Wells Fargo
Wells Fargo analyst Jim Birchenough started Global Blood Therapeutics with an Outperform rating and $75-$81 price target range. The analyst has a positive outlook for the company's hemoglobin modifier GBT440 in Sickle Cell Disease. He views GBT440 as a best-in-class hemoglobin modifier and estimates peak sales at $2.7B.

TODAY'S FREE FLY STORIES

FB

Facebook

$171.11

-1.06 (-0.62%)

14:53
09/22/17
09/22
14:53
09/22/17
14:53
Periodicals
Facebook settles lawsuit over non-voting shares, Business Insider reports »

Facebook settled a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

XOP

SPDR Oil Exploration and Production Fund

$33.00

0.09 (0.27%)

14:50
09/22/17
09/22
14:50
09/22/17
14:50
Options
SPDR Oil Exploration and Production ETF puts outpace calls 6:1 »

SPDR Oil Exploration and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTXI

GTx

$8.74

0.17 (1.98%)

14:48
09/22/17
09/22
14:48
09/22/17
14:48
Conference/Events
GTx, Inc to hold a KOL luncheon meeting »

Management hosts a KOL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXPE

Expedia

$143.12

0.11 (0.08%)

14:45
09/22/17
09/22
14:45
09/22/17
14:45
Options
Expedia call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$74.21

-7.54 (-9.22%)

14:35
09/22/17
09/22
14:35
09/22/17
14:35
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$9.81

-0.13 (-1.31%)

14:27
09/22/17
09/22
14:27
09/22/17
14:27
Hot Stocks
Spectrum lower after Twitter highlights failed trial in Korea »

Shares of Spectrum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DLPH

Delphi

$102.58

1.54 (1.52%)

14:21
09/22/17
09/22
14:21
09/22/17
14:21
Conference/Events
Delphi to hold investor update meeting »

Investor Update Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

$NSD

NASDAQ Market Internals

14:17
09/22/17
09/22
14:17
09/22/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
09/22/17
09/22
14:16
09/22/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$117.03

0.56 (0.48%)

14:15
09/22/17
09/22
14:15
09/22/17
14:15
Options
Chevron put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 09

    Nov

S

Sprint

$8.42

0.39 (4.86%)

, TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

14:12
09/22/17
09/22
14:12
09/22/17
14:12
Periodicals
Sprint hired lobbyist tied to Trump in September, Reuters says »

Sprint (S) hired a…

S

Sprint

$8.42

0.39 (4.86%)

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

OPK

OPKO Health

$6.48

0.15 (2.37%)

14:05
09/22/17
09/22
14:05
09/22/17
14:05
Options
Opko Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

14:05
09/22/17
09/22
14:05
09/22/17
14:05
General news
Dallas Fed hawk Kaplan is open minded about one more hike »

Dallas Fed hawk Kaplan is…

GWRE

Guidewire

$78.42

1.26 (1.63%)

14:04
09/22/17
09/22
14:04
09/22/17
14:04
Conference/Events
Guidewire to host analyst day »

Analyst Day to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCPT

Four Corners Property Trust

$25.05

-0.27 (-1.07%)

, WPG

Washington Prime

$8.13

0.095 (1.18%)

14:02
09/22/17
09/22
14:02
09/22/17
14:02
Recommendations
Four Corners Property Trust, Washington Prime analyst commentary  »

Four Corners Property…

FCPT

Four Corners Property Trust

$25.05

-0.27 (-1.07%)

WPG

Washington Prime

$8.13

0.095 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.75

-0.76 (-1.22%)

, UNH

UnitedHealth

$188.70

-6.51 (-3.33%)

14:02
09/22/17
09/22
14:02
09/22/17
14:02
Hot Stocks
Health insurers jump as McCain comes out against latest repeal/replace effort »

Shares of a number of…

MOH

Molina Healthcare

$61.75

-0.76 (-1.22%)

UNH

UnitedHealth

$188.70

-6.51 (-3.33%)

CNC

Centene

$87.58

-3.16 (-3.48%)

WCG

WellCare

$163.07

-2.99 (-1.80%)

CI

Cigna

$181.14

-0.99 (-0.54%)

ANTM

Anthem

$181.21

-2.29 (-1.25%)

HNT

Health Net

HUM

Humana

$235.79

-2.85 (-1.19%)

AET

Aetna

$150.76

-2.63 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

ICPT

Intercept

$73.70

-24.42 (-24.89%)

13:57
09/22/17
09/22
13:57
09/22/17
13:57
Downgrade
Intercept rating change  »

Oppenheimer downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$46.29

0.87 (1.92%)

13:57
09/22/17
09/22
13:57
09/22/17
13:57
Hot Stocks
Trump thanks American Airlines for 'fantastic job' with hurricane flights »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

IWM

iShares Trust Russell 2000 Index Fund

$144.38

0.69 (0.48%)

, RUT

Russell 2000 Index

13:53
09/22/17
09/22
13:53
09/22/17
13:53
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$144.38

0.69 (0.48%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.77

-0.74 (-1.18%)

, UNH

UnitedHealth

$189.08

-6.13 (-3.14%)

13:53
09/22/17
09/22
13:53
09/22/17
13:53
Periodicals
McCain says cannot vote for Graham-Cassidy healthcare bill, Bloomberg reports »

Publicly traded companies…

MOH

Molina Healthcare

$61.77

-0.74 (-1.18%)

UNH

UnitedHealth

$189.08

-6.13 (-3.14%)

CNC

Centene

$87.61

-3.13 (-3.45%)

WCG

WellCare

$162.70

-3.36 (-2.02%)

CI

Cigna

$181.18

-0.9483 (-0.52%)

ANTM

Anthem

$181.24

-2.26 (-1.23%)

HNT

Health Net

HUM

Humana

$235.91

-2.735 (-1.15%)

AET

Aetna

$150.81

-2.58 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

XLE

Energy Select Sector SPDR

$67.08

0.22 (0.33%)

, XLI

Industrial Select Sector SPDR

$70.76

0.19 (0.27%)

13:51
09/22/17
09/22
13:51
09/22/17
13:51
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

For the week, the S&P…

XLE

Energy Select Sector SPDR

$67.08

0.22 (0.33%)

XLI

Industrial Select Sector SPDR

$70.76

0.19 (0.27%)

XLF

Financial Select Sector

$25.43

-0.035 (-0.14%)

XLB

S&P Select Materials SPDR

$56.57

-0.18 (-0.32%)

XLP

Consumer Staples Sector SPDR

$53.97

-0.115 (-0.21%)

XLU

Utilities SPDR

$53.43

-0.24 (-0.45%)

XLV

Health Care Select Sector SPDR

$81.25

-0.33 (-0.40%)

SPY

SPDR S&P 500 ETF Trust

$249.16

-0.23 (-0.09%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$54.07

0.16 (0.30%)

, UGI

UGI Corporation

$47.06

-0.28 (-0.59%)

13:50
09/22/17
09/22
13:50
09/22/17
13:50
Periodicals
Total sells Total Italia Gas to UGI Corporation, Reuters reports »

Total (TOT) has sold its…

TOT

Total

$54.07

0.16 (0.30%)

UGI

UGI Corporation

$47.06

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$21.56

0.3975 (1.88%)

13:50
09/22/17
09/22
13:50
09/22/17
13:50
Options
One-week option play opened in Macy's »

One-week option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ICPT

Intercept

13:48
09/22/17
09/22
13:48
09/22/17
13:48
Downgrade
Intercept rating change  »

Intercept downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXAS

Exact Sciences

$45.00

1.6 (3.69%)

13:40
09/22/17
09/22
13:40
09/22/17
13:40
Options
Longer-term spread opened in Exact Sciences »

Longer-term spread opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.